Stay updated on Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-12T18:15:05.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T22:42:28.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    1%
    Check dated 2024-12-07T16:12:02.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has added new features, while several detailed data fields and options for downloading study information have been removed.
    Difference
    2%
    Check dated 2024-11-23T04:39:05.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several key medical and genetic resource links related to multiple myeloma and associated treatments have been removed, which may impact access to important information.
    Difference
    0.4%
    Check dated 2024-11-15T23:50:05.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with new additions including multiple resources related to multiple myeloma, clinical trials, and medication information, while the previous version 2.12.1 has been removed.
    Difference
    3%
    Check dated 2024-11-08T18:26:40.000Z thumbnail image

Stay in the know with updates to Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.